Real-World Biomarker Testing and Treatment Patterns for Locally Advanced and Metastatic Non-Small Cell Lung Cancer in Canada

被引：0
|
作者：
Laforty, C. [1 ]
Tong, M. [1 ]
Sharma, A. [2 ]
Kim, Y. [3 ]
Devost, N. [3 ]
Qadeer, R. [3 ]
Navani, V. [4 ]
机构：
[1] IQVIA, Toronto, ON, Canada
[2] IQVIA, Ottawa, ON, Canada
[3] AstraZeneca Canada, Mississauga, ON, Canada
[4] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Locally Advanced and Metastatic NSCLC; Biomarker; Treatment Patterns;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.12G.02
引用
收藏
页码：S656 / S657
页数：2
相关论文
共 50 条
  • [41] Overall survival and treatment patterns among real-world patients with metastatic non-small cell lung cancer not previously treated with systemic therapy for advanced cancer
    Simeone, Jason C.
    Nordstrom, Beth L.
    Patel, Ketan
    Klein, Alyssa B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 101 - 102
  • [42] Crizotinib In Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Curran, Monique P.
    DRUGS, 2012, 72 (01) : 99 - 107
  • [43] PD-L1 Testing Patterns and Treatment in Patients With Metastatic Non-Small Cell Lung Cancer in Israel - Analysis of Real-World Data
    Apter, L.
    Moser, S. Sharman
    Arunachalam, A.
    Burke, T.
    Shalev, V.
    Chodick, G.
    Siegelmann-Danieli, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S307 - S308
  • [44] Treatment of Locally Advanced Non-Small Cell Lung Cancer
    Tam, Kit
    Daly, Megan
    Kelly, Karen
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 45 - +
  • [45] Real-world data on nivolumab treatment of non-small cell lung cancer
    Brustugun, O. T.
    Sprauten, M.
    Helland, A.
    ACTA ONCOLOGICA, 2017, 56 (03) : 438 - 440
  • [46] Real-world experience of treatment with afatinib in advanced non-small cell lung cancer (NSCLC) in Vietnam
    Dong, H.
    Tuan, K. Nguyen
    Bui, T. T. P.
    Dong, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1590 - S1590
  • [47] The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast
    Hirsch, Fred R.
    Kim, Chul
    ONCOLOGY AND THERAPY, 2024, 12 (02) : 223 - 231
  • [48] A real-world experience of immune checkpoint inhibitors: immunotherapy related adverse events for locally advanced and metastatic non-small cell lung cancer
    Sidon, L.
    Dillon, M.
    Power, D.
    Dubash, S.
    LUNG CANCER, 2020, 139 : S49 - S49
  • [49] Real-world disease characteristics and treatment patterns in patients with advanced non-small cell lung cancer and EGFR in Brazil and Taiwan
    Bailey, H.
    Burlison, H.
    Chandrasekar, S.
    Wong, C. H.
    Forshaw, C.
    Duncan, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S58 - S58
  • [50] Treatment Patterns, Clinical Outcomes and Healthcare Costs of Advanced Non-Small Cell Lung Cancer: A Real-World Evaluation in Italy
    Franchi, Matteo
    Cortinovis, Diego
    Corrao, Giovanni
    CANCERS, 2021, 13 (15)
12345